Machine learning enhances risk stratification and treatment failure prediction in diffuse large B‐cell lymphoma

Documenti analoghi

• Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma
  di: Sirpa Leppä, et al.
  Pubblicazione: (2025)
• Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer
  di: Christian Brieghel, et al.
  Pubblicazione: (2025)
• Delving deeper into the pathogenesis and genomics of posttransplant diffuse large B‐cell lymphoma
  di: Flore Sneyers, et al.
  Pubblicazione: (2025)
• Outcomes and treatment patterns of patients with primary mediastinal B‐cell lymphoma after CAR‐T cell therapy failure: A DESCAR‐T analysis
  di: Jean Galtier, et al.
  Pubblicazione: (2025)
• The changing influence of neighborhood socioeconomic status on long‐term survival in diffuse large B‐cell lymphoma patients: A German metropolitan case‐control study spanning over three decades
  di: Susanne Ghandili, et al.
  Pubblicazione: (2024)